myocarditis, diffuse myocardial disease, idiopathic cardiomegaly, idiopathic cardiac hypertrophy, and familial cardiomyopathy or cardiomegaly. Differences in terminology and classification have been a major contributing factor to present and past confusion. Some authors confine the term to include only those patients with unknown etiology (idiopathic group); others include in addition, many known conditions affecting the myocardium (table 1) .
We prefer a broader classification (as does Mattingly) that differs from some of the other contributors in this symposium and includes both known or specific causes and unknown or idiopathic. We have divided our patients into two groups-one a specific etiology and the other idiopathic. It has been our clinical impression that regardless of whether the specific causes of primary myocardial disease were known or unknown, the clinical features and course were often quite similar. Analysis of a large number of our patients has supported this clinical impression. We also believe and predict that with earlier Circulation, Volume XXXII, November 1965 diagnosis and careful follow-up many patients now designated as idiopathic will, in the future, be documented as having one of the specific etiologies, such as infectious (viral or bacterial) or hypersensitivity phenomena.
An analysis of 216 patients with the diagnosis of primary myocardial disease studied at Georgetown University Hospital is shown in table 2. In the specific etiology group, including those with the diagnosis established at autopsy, the deceased outnumber the living. Of 159 patients designated as idiopathic the majority are living, and most are being followed at regular intervals on an outpatient basis. These patients represent both private and ward patients. Most are in the middle socioeconomic group, the white outnumbering Negro 97 to 62. Ninety-six patients of the 159 were male, and 63 were female. The usual onset of symptoms of primary myocardial disease was between the ages of 20 to 50.
Clinical Features
The clinical and diagnostic features of our patients are discussed in detail elsewhere,' but are illustrated in table 3. Symptoms and signs of congestive failure are the most common features, and the severity of congestive heart failure varied from mild to severe, occasionally even acute pulmonary edema. The next in frequency are arrhythmias. Other symptoms are chest pain, pleuritic in type, and less commonly ischemic pain of myocardial origin. Emboli, both systemic and pulmonary, may be present. Not infrequent were nonspecific complaints such as weakness and fatigue.
Conduction disturbances were common ( Arrhythmias involving the atria and ventricles were common, varying from extrasystoles to tachyeardias. Atrial fibrillation was much more common than atrial flutter. An occasional patient may show ventricular tachycardia as the first indication of this disease.
At other times Stokes-Adams syncopal episodes have represented the first sign of myocardial disease. Some have had pericarditis associated with myocarditis. At first the diagnosis of myocarditis may not be suspected because of the initial predominant symptoms and signs related to the pericarditis. Thromboembolic disease with both pulmonary and peripheral arterial emboli have generally been noted in the majority of the larger series of patients reported in the literature. Emboli may originate from mural thrombi from either the right or left side of the heart. In patients having advanced cardiac decompensation, thrombophlebitis of pelvic or leg veins represents a potential complication and pulmonary emboli may also occur from this source. At times a patient may have the typical features of pulmonary hypertension, which may cause confusion with other causes of pulmonary hypertension, such as that associated with congenital heart disease or resulting from recurrent pulmonary emboli.
Cardiomegaly is present in the majority and is a characteristic feature of primary myocardial disease. Although the majority have significant cardiac enlargement on x-ray, some have only slight to moderate enlargement. Uncommonly the heart size appears normal. We have seen several patients with apparently normal heart size, but who have had serious or even fatal arrhythmias. Not infrequently the heart is greatly enlarged and Circulation, Volume XXXII, November 1965 I. IL. A pericardial friction rub often represents the first indication of pericarditis, which may be associated with myocarditis. A less common finding is a sound in diastole, generally earlier than the timing of a ventricular diastolic gallop and corresponding with the timing of the pericardial knock sound heard in constrictive pericarditis. When present in primary myocardial disease, however, it is more likely a filling sound resulting from a restrictive type of myocardium rather than a constrictive pericardium. At times the differential diagnosis between constrictive pericarditis and restrictive primary myocardial disease may be quite difficult even after careful clinical and hemodynamic studies.
Systolic murmurs are common, the most frequent being mitral. A short systolic murmur may be heard over the pulmonary area and less commonly over the aortic area. More advanced degrees of cardiac decompensation resulting in tricuspid insufficiency produce a pansystolic murmur over the tricuspid area that may increase in intensity with inspiration.
Electrocardiogram
As shown in changes represent the most common findings; arrhythmias and conduction disturbances as already discussed are frequent.
X-ray of the Heart
Cardiac enlargement is usually present. Rarely the heart size is normal. With treatment the heart size may decrease. In some, enlargement persists despite all known forms of treatment; still others show progressive increase in size over months or years. Pulmonary congestion and pleural effusion of varying degrees may be noted. Occasionally acute pulmonary edema may lead the patient to seek medical advice.
The Spectrum of Primary Myocardial Disease Primary myocardial disease represents a broad spectrum in regard to pathology, symptoms and signs, course, and prognosis. Some patients have moderately severe involvement of the myocardium which may eventually go on to recovery and leave little residual damage. Others remain fairly stable with chronic cardiac decompensation. Still others have a progressive deteriorating course terminating in death. Some appear to have mild residual myocardial damage, others moderately severe, and still others severe. It is our clinical impression that the amount of residual damage correlates with the subsequent symptoms and signs as well as with prognosis.
Sudden death is not uncommon, and occurred in nine patients of 35 in the idiopathic group dying with primary myocardial disease. The incidence of sudden death probably is even higher, since in seven patients in the idiopathic group it could not be determined whether death was sudden.
If one thinks of primary myocardial disease in the concept of a spectrum, the disease will be much less confusing. The patient with mild myocardial involvement usually has more complete recovery. On the other hand, the patient with unrecognized myocardial involvement (even though mild) not receiving proper treatment may progress to moderately severe or severe involvement terminating either in death or a serious form of chronic heart disease. It is also possible for those patients with moderately severe or severe Circulation, Volumne XXXII, November 1965 degrees of involvement to have reversal of their disease with little or no residual damage, particularly if there has been early diagnosis and treatment. It is highly possible that more people than generally realized have, at some time in the past, had a mild degree of myocardial disease. Possibly this was due to a viral infection that may have been unrecognized and left no residual cardiac damage. It is also probable that similar unrecognized cases have progressed into a serious irreversible state of myocardial damage, and may now be designated as "idiopathic" myocardial disease.
Treatment of Primary Myocardial Disease
The treatment of primary myocardial disease leaves much to be desired. Certainly the over-all results of treatment have been poor, particularly in the advanced stages of the spectrum of the disease. It has been said that treatment is of no avail and that the course of the disease is characterized by progressive deterioration. An understanding of the pathology of the disease well explains why any type of treatment would be unlikely to benefit significantly those patients with advanced chronic disease whose myocardium has been replaced by extensive fibrosis and degenerative changes. It is also understandable why hearts with extensive involvement would be more sensitive to drugs that usually produce a beneficial effect on myocardial tissue, such as digitalis or quinidine. If one diagnoses only those patients in the far-advanced group and has not observed those at the milder end of the spectrum, a pessimistic outlook would prevail. On the other hand, if one recognizes that early diagnosis is often missed or confused with other types of heart disease, that it is a more prevalent disease than formerly appreciated, and that there may be varying degrees of severity, then perhaps something tangible in the form of treatment might be forthcoming. Experience of treatment in our own group of patients, together with the other contributors to this symposium on treatment have focused on the following basic fundamentals of treatment.
It has been well emphasized by Dr. George Burch and his associates that strict bed rest has often been beneficial in treatment. A prolonged period of bed rest for one or more years imposes a problem on many patients and their families. In a number of instances it is not possible because of financial or other reasons to carry out such long periods of rest, even though, theoretically, this would be advisable. Compromise of shorter periods of rest from several weeks to several months has in some also been beneficial, as evidenced by reduction of heart size and improvement in symptoms and signs of cardiac decompensation. It seems logical, therefore, to utilize rest, a simple and basic form of treatment, as a fundamental requirement not only for patients having more severe degree of involvement, but also even in the milder or moderately severe degrees of involvement of the spectrum. It is conceivable that the most significant and lasting effect of the benefit of rest in treatment may well be in the lesser degrees of myocardial involvement. It is possible that early institution of rest may have a preventive effect on progression of the disease, allaying or preventing a course leading to an irreversible state, and also theoretically promoting improvement as well as possible recovery.
Each of the contributors in this symposium lists rest as one of the most important aspects of treatment. Whether bed rest should be strictly enforced or be modified with slightly more lenient regulations may vary. It should be individualized by the physician, as one employs rest in the treatment of acute myocardial infarction.
Treatment of Congestive Heart Failure
Since symptoms and signs of cardiac decompensation are present in the majority of patients with primary myocardial disease, the usual and accepted forms of treatment in addition to that of rest are necessary.
Digitalization
When congestive heart failure is present, digitalis is indicated. Despite the numerous warnings concerning the increased sensitivity and toxicity of digitalis in patients with primary myocardial disease, we have found that the great majority of patients not only have a need for digitalis, but are able to tolerate it without difficulty. At times, however, unusual sensitivity may indeed be present. Although all digitalis preparations are effective, we prefer digoxin rather than longer-acting preparations, at least during the initial digitalization. In case the patient is more sensitive to the drug, evidences of it would appear sooner with the shorter acting glycoside and faster elimination would occur if the drug is discontinued. Our practice has been to digitalize the patient slowly, stopping at any signs of toxicity. We "under-shoot" rather than give a full digitalizing dose, and for maintenance use a smaller dose, such as 0.25 mg. rather than 0.5 mg. daily. Digitalis toxicity manifested predominantly by increased ventricular irritability or other arrhythmias, including paroxysmal atrial tachycardia with block, was noted in 15 of 150 patients who received digitalis (table 5). The importance of adequate restriction of sodium in the diet of patients having cardiac decompensation cannot be overemphasized.
Treatment of Arrhythmias
Treatment of various arrhythmias that may be present with primary myocardial disease has been outlined in Dr. Mattingly's section and will not be repeated here. Table 5 also outlines quinidine therapy in 41 patients in whom there was an attempt at reversion of atrial fibrillation or flutter. Reversion was successful in 20.
Steroids
The use of steroids in treatment of primary myocardial disease is controversial, as illustrated by the opinions from the various contributors in this symposium. Our results included in table 5 represent clinical impressions rather than definite scientific evidence. It appears that those who may derive possible benefit are (a) those patients with primary myocardial disease resulting from so-called collagen diseases, sarcoidosis, trichinosis, etc., (b) those manifesting various arrhythmias such as frequent ventricular extrasystoles, atrial, nodal, and ventricular tachycardia, and various conduction defects, including complete heart block with Stokes-Adams syncope, (c) in patients in whom a trial of the usual measures for control of cardiac decompensation or arrhythmias has been without success, and (d) in some acute, severely ill patients.
No benefit could be expected for a patient whose myocardium already has extensive fibrosis and destruction, representing an irreversible type of injury. In fact, in some, steroids may potentiate the disease process or possibly even produce myocardial injury. The use of steroids, therefore, must still be individualized.
Anticoagulants
Although a large series of patients with primary myocardial disease have not been subjected to critical analysis concerning the possible beneficial effects, the use of anticoagulants appears justified on theoretical grounds, and it is the consensus of all contributors to this symposium that anticoagulants have a place in treatment. This is based on the fact that embolic phenomena often occur in patients with primary myocardial disease, as illustrated in table 6. Twenty-two embolic episodes occurred in 173 patients of the idiopathic group. Systemic emboli were about twice as common as pulmonary emboli. Eleven of these patients received anticoagulant therapy, and two embolic episodes occurred at a time when the patient was receiving anticoagulants. Emboli are known to occur from mural thrombi from either the right or left side of the heart, and therefore pulmonary or systemic emboli represent a significant complication of this disease. In addition, since patients with congestive heart failure, particularly of a chronic type (as is frequently the case with primary myocardial disease) are more likely to have thrombophlebitis involving leg or pelvic veins, pulmonary emboli can also originate from these sources.
Although it is apparent that treatment of primary myocardial disease is symptomatic, there may well be a preventive aspect. In those in whom a definite infection is documented, treatment with appropriate antibiot- ics would be indicated. In any instance when there is a possibility of a toxic agent, its elimination is obviously indicated. Also, in the treatment of so-called alcoholic myopathy the avoidance of intake of alcohol would be appropriate in addition to the other measures already stressed. It appears evident that treatment must be centered around early diagnosis, and once the diagnosis is established or strongly suspected, bed rest and medication must be initiated promptly. These may well be significant factors determining whether the myo-cardial involvement can be arrested, reversed, or cured. Reference* 1. HARVEY, W. P., SEGAL, J. P., AND GuREL, T.:
The clinical spectrum of primary myocardial disease. Progr. Cardiovas. Dis. Vol. 7, No. I (July) 1964.
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